S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume

$4.00
-0.30 (-6.98%)
(As of 04/19/2024 ET)

Relmada Therapeutics Short Interest Data

Current Short Volume
1,690,000 shares
Previous Short Volume
1,750,000 shares
Change Vs. Previous Month
-3.43%
Dollar Volume Sold Short
$7.86 million
Short Interest Ratio / Days to Cover
7.4
Last Record Date
March 31, 2024
Outstanding Shares
30,170,000 shares
Percentage of Shares Shorted
5.60%
Today's Trading Volume
152,611 shares
Average Trading Volume
125,003 shares
Today's Volume Vs. Average
122%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Relmada Therapeutics ?

Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RLMD Short Interest Over Time

RLMD Days to Cover Over Time

RLMD Percentage of Float Shorted Over Time

Relmada Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65
3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42
2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13
2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27
1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93
1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14
12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14
12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48
11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47
11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03
10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99
10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10
9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00
9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09
8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38
8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41
7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62
7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84
6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46
6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55
5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84
5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09
4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52
4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71
3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26
3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56
2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60
2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71
1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06
1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12
12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49
12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14
11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65
11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89
10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39
10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20
9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02
9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39
8/31/20223,250,000 shares $94.71 million +3.2%N/A11.9 $29.14
8/15/20223,150,000 shares $91.79 million +1.0%N/A12.3 $29.14
Global crypto currency reset (41 major banks signed up) (Ad)

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

 Here's everything you need to know.

RLMD Short Interest - Frequently Asked Questions

What is Relmada Therapeutics' current short interest?

Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 1,690,000 shares of RLMD short. Learn More on Relmada Therapeutics' current short interest.

What is a good short interest ratio for Relmada Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 7.0. Learn More on Relmada Therapeutics's short interest ratio.

Which institutional investors are shorting Relmada Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relmada Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Relmada Therapeutics' short interest increasing or decreasing?

Relmada Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 1,690,000 shares, a decrease of 3.4% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Relmada Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Relmada Therapeutics: GlycoMimetics, Inc. (2.47%), Amylyx Pharmaceuticals, Inc. (12.63%), Rezolute, Inc. (0.63%), Sagimet Biosciences Inc. (19.41%), I-Mab (1.45%), FibroGen, Inc. (5.65%), Spyre Therapeutics, Inc. (9.36%), Syros Pharmaceuticals, Inc. (9.89%), Karyopharm Therapeutics Inc. (19.94%), Eliem Therapeutics, Inc. (0.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Relmada Therapeutics stock?

Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. RLMD shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Relmada Therapeutics?

A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further.

How often is Relmada Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RLMD) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners